Order Article Reprints

Nogueira BMD, da Costa Pantoja L, da Silva EL, Mello Júnior FAR, Teixeira EB, Wanderley AV, da Silva Maués JH, de Moraes Filho MO, de Moraes MEA, Montenegro RC, et al. Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia. Genes. 2021; 12(10):1632. https://doi.org/10.3390/genes12101632

Nogueira, Beatriz Maria Dias, Laudreísa da Costa Pantoja, Emerson Lucena da Silva, Fernando Augusto Rodrigues Mello Júnior, Eliel Barbosa Teixeira, Alayde Vieira Wanderley, Jersey Heitor da Silva Maués, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro, and et al. 2021. "Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia" Genes 12, no. 10: 1632. https://doi.org/10.3390/genes12101632

Nogueira, B. M. D., da Costa Pantoja, L., da Silva, E. L., Mello Júnior, F. A. R., Teixeira, E. B., Wanderley, A. V., da Silva Maués, J. H., de Moraes Filho, M. O., de Moraes, M. E. A., Montenegro, R. C., Khayat, A. S., & Moreira-Nunes, C. A. (2021). Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia. Genes, 12(10), 1632. https://doi.org/10.3390/genes12101632